Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tezspire
Pharma
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
A phase 3 study has shown that AZ and Amgen's Tezspire worked in patients with severe chronic rhinosinusitis with nasal polyps.
Kevin Dunleavy
Nov 8, 2024 3:31pm
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
Dupixent data enhance Sanofi, Regeneron's pursuit of COPD nod
May 20, 2024 2:24pm
Amgen, AZ see Tezspire's promise in COPD despite trial miss
May 20, 2024 10:16am
Amgen, AstraZeneca focus on punk rocker in latest Tezspire ad
Sep 15, 2023 8:40am
AZ's Fasenra shows comparable efficacy in trial vs. GSK's Nucala
Sep 12, 2023 9:01am
